United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,023,000 | 953,000 | 837,500 | 846,800 | 831,800 |
| Marketable Securities | 27,800 | 79,600 | 107,200 | 128,300 | 122,000 |
| Receivables | 214,500 | 224,600 | 238,100 | 194,800 | 192,800 |
| Inventories | 100,000 | 92,400 | 89,100 | 87,600 | 81,300 |
| Other current assets | 59,500 | 36,400 | 43,500 | 42,100 | 47,400 |
| TOTAL | $1,424,800 | $1,386,000 | $1,315,400 | $1,299,600 | $1,275,300 |
| Non-Current Assets | |||||
| PPE Net | 489,300 | 488,400 | 490,600 | 495,200 | 495,800 |
| Investments And Advances | 2,300 | 2,300 | 3,900 | 10,700 | 38,000 |
| Other Non-Current Assets | 409,200 | 392,500 | 391,600 | 386,600 | 375,300 |
| TOTAL | $900,800 | $883,200 | $886,100 | $892,500 | $909,100 |
| Total Assets | $2,325,600 | $2,269,200 | $2,201,500 | $2,192,100 | $2,184,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 900 | 5,400 | N/A |
| Accounts payable and accrued liabilities | 104,200 | 119,000 | 124,000 | 106,600 | 103,400 |
| Other current liabilities | 228,300 | 195,600 | 167,500 | 245,100 | 337,300 |
| TOTAL | $332,500 | $314,600 | $292,400 | $357,100 | $440,700 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 141,800 | 115,900 | 102,900 | 123,200 | 155,100 |
| TOTAL | $141,800 | $115,900 | $102,900 | $123,200 | $155,100 |
| Total Liabilities | $474,300 | $430,500 | $395,300 | $480,300 | $595,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,962 | 42,415 | 43,468 | 44,622 | 45,353 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 2,433,500 | 2,323,200 | 2,161,400 | 1,955,300 | 1,719,800 |
| Other shareholders' equity | -16,400 | -16,900 | -14,600 | -19,300 | -20,500 |
| TOTAL | $1,851,300 | $1,838,700 | $1,806,200 | $1,711,800 | $1,588,600 |
| Total Liabilities And Equity | $2,325,600 | $2,269,200 | $2,201,500 | $2,192,100 | $2,184,400 |